InvestorsHub Logo
Followers 39
Posts 4232
Boards Moderated 0
Alias Born 02/23/2012

Re: None

Sunday, 11/24/2013 3:09:43 PM

Sunday, November 24, 2013 3:09:43 PM

Post# of 1123
The market over reacted to merck giving back the global marketing & developement rights of Brivaness to Cardiome. It was look at as having a negative effect on crme. Boy what a mistake. That was just a year ago. Now it looks like we could have the fda hold removed & the stock should move back to & above the $40 level. Piling on with the acquisition of a revenue generating company, this is a $50+ company.